Literature DB >> 31736412

Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2.

Shaobin Li1, Xiaoge Niu2, Hui Li1, Yanan Liang1, Zhengyang Sun1, Yusheng Yan1.   

Abstract

Background: Circular RNAs (circRNAs) play a pivotal regulatory role in a variety of tumors.Nevertheless, the detailed function of circ_0000003 in non-small cell lung cancer (NSCLC) and its regulatory mechanism remain elusive.
Methods: RT-PCR was carried out to detect the expressions of circ_0000003, miR-338-3p and insulin receptor substrate 2 (IRS2)in NSCLC tissues. Besides, western blot was done to monitor IRS2 expression in NSCLC cells. The correlation between circ_0000003 and clinicopathologic characteristics of NSCLC patients was analyzed as well.CCK8 and BrdUassays were used to monitor cell proliferation; flow cytometry was used to detect apoptosis; and transwell assay was conducted to detect its migration and invasion.Moreover, dual luciferase reporter gene assay was done to verify the targeting relationship between circ_0000003 and miR-338-3p.Additionally, the effect of circ_0000003 on the growth of NSCLC cells in vivo was evaluated by tumorigenesis assay in nude mice.
Results: The expression of circ_0000003 was significantly high in NSCLC tissues and cell lines, and its high expression level was notably correlated with lymph node metastasis andTNM staging.In vitro experiments showed that overexpression of circ_0000003 facilitated the proliferation, migration, invasion and inhibited the apoptosis of NSCLC cells, while the knockdown of circ_0000003 had the opposite effect.In vivo experiments revealed that knockdown of circ_0000003 impeded tumor growth and metastasis. Further, the underlying mechanism showed that circ_0000003 functioned as endogenous competitive RNA and directly targeted miR-338-3p to positively regulated IRS2 expression.
Conclusion: Circ_0000003 promotes the proliferation and metastasis of NSCLC cells via modulating miR-338-3p/IRS2 axis.

Entities:  

Keywords:  NSCLC; circ_0000003; miR-338-3p

Year:  2019        PMID: 31736412      PMCID: PMC6927718          DOI: 10.1080/15384101.2019.1690883

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  44 in total

1.  Overexpression of LINC00261 inhibits non-small cell lung cancer cells progression by interacting with miR-522-3p and suppressing Wnt signaling.

Authors:  Jingli Shi; Huimin Ma; Huaixi Wang; Weiyan Zhu; Shuting Jiang; Rui Dou; Beizhan Yan
Journal:  J Cell Biochem       Date:  2019-06-12       Impact factor: 4.429

2.  MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4.

Authors:  M Zhang; H Shi; C Zhang; S-Q Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-06       Impact factor: 3.507

3.  microRNA-448 inhibits the progression of non-small-cell lung cancer through regulating IRS2.

Authors:  Jie Gao; Xiaojing Feng; Fang Wang; Junlan Wang; Hongmei Wang; Hua Li; Weiwei Zhang; Lijun Hao; Zhiming Shi
Journal:  J Cell Biochem       Date:  2019-03-25       Impact factor: 4.429

Review 4.  CircRNA: a novel type of biomarker for cancer.

Authors:  He-da Zhang; Lin-Hong Jiang; Da-Wei Sun; Jun-Chen Hou; Zhen-Ling Ji
Journal:  Breast Cancer       Date:  2017-07-18       Impact factor: 4.239

Review 5.  CircRNA: functions and properties of a novel potential biomarker for cancer.

Authors:  Shujuan Meng; Hecheng Zhou; Ziyang Feng; Zihao Xu; Ying Tang; Peiyao Li; Minghua Wu
Journal:  Mol Cancer       Date:  2017-05-23       Impact factor: 27.401

Review 6.  Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis.

Authors:  João Agostinho Machado-Neto; Bruna Alves Fenerich; Ana Paula Nunes Rodrigues Alves; Jaqueline Cristina Fernandes; Renata Scopim-Ribeiro; Juan Luiz Coelho-Silva; Fabiola Traina
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

Review 7.  Emerging Epigenetic Regulation of Circular RNAs in Human Cancer.

Authors:  Jie Wu; Xiaoqian Qi; Lina Liu; Xin Hu; Jingwen Liu; Jianming Yang; Jun Yang; Lu Lu; Zheng Zhang; Shiqing Ma; Hongfa Li; Xinyue Yun; Tong Sun; Yue Wang; Zuomin Wang; Zihao Liu; Wei Zhao
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-19

8.  MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2.

Authors:  Haiyan Wang; Fangfang Zhao; Shanbao Cai; Youguang Pu
Journal:  J Bone Oncol       Date:  2019-05-11       Impact factor: 4.072

Review 9.  The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment.

Authors:  Lorena Verduci; Sabrina Strano; Yosef Yarden; Giovanni Blandino
Journal:  Mol Oncol       Date:  2019-02-18       Impact factor: 6.603

10.  The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.

Authors:  Zongli Ding; Jianjie Zhu; Yuanyuan Zeng; Wenwen Du; Yang Zhang; Haicheng Tang; Yulong Zheng; Hualong Qin; Zeyi Liu; Jian-An Huang
Journal:  Mol Carcinog       Date:  2019-02-27       Impact factor: 4.784

View more
  10 in total

1.  Circular RNA EPB41 expression predicts unfavorable prognoses in NSCLC by regulating miR-486-3p/eIF5A axis-mediated stemness.

Authors:  Mingming Jin; Xiyu Liu; Yue Wu; Yuqing Lou; Xue Li; Gang Huang
Journal:  Cancer Cell Int       Date:  2022-06-20       Impact factor: 6.429

2.  circRNA Hsa_circ_0020850 Silence Represses the Development of Lung Adenocarcinoma via Regulating miR-195-5p/IRS2 Axis.

Authors:  Tuye Xin; Shuangshuang Li; Ying Zhang; Xiayizha Kamali; Hui Liu; Tengfei Jia
Journal:  Cancer Manag Res       Date:  2020-10-28       Impact factor: 3.989

3.  Circular RNA circ_0010235 sponges miR-338-3p to play oncogenic role in proliferation, migration and invasion of non-small-cell lung cancer cells through modulating KIF2A.

Authors:  Yanan Zhu; Chunling Ma; Aiai Lv; Changwei Kou
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

4.  Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis.

Authors:  Cuijuan Qian; Shihang Chen; Sen Li; Yichao Wang; Jun Yao
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

5.  CircHIPK3/miR-381-3p axis modulates proliferation, migration, and glycolysis of lung cancer cells by regulating the AKT/mTOR signaling pathway.

Authors:  Feng Gu; Junhan Zhang; Lin Yan; Dong Li
Journal:  Open Life Sci       Date:  2020-09-06       Impact factor: 0.938

6.  hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G1/S cell cycle progression, and repressing cell apoptosis via crosstalk with miR-338-3p and SOX4.

Authors:  Qiang Luo; Feng Guo; Qingfeng Fu; Guoqing Sui
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-24       Impact factor: 8.886

7.  Hsa_circRNA_0017620 regulated cell progression of non-small-cell lung cancer via miR-520a-5p/KRT5 axis.

Authors:  Shan Chen; Kelin Hong; Long Zhou; Ruizhi Ran; Jinqi Huang; Yong Zheng; Maohui Xing; Yanli Cai
Journal:  J Clin Lab Anal       Date:  2022-03-18       Impact factor: 2.352

8.  circHUWE1 Exerts an Oncogenic Role in Inducing DDP-Resistant NSCLC Progression Depending on the Regulation of miR-34a-5p/TNFAIP8.

Authors:  Xueliang Yang; Quan Sun; Yongming Song; Wenli Li
Journal:  Int J Genomics       Date:  2021-12-03       Impact factor: 2.326

9.  Hsa_circ_0006427 Suppresses Multiplication, Migration and Invasion of Non-Small Cell Lung Cancer Cells through miR-346/VGLL4 Pathway.

Authors:  Jia Cheng Sun; Lei Wang; Xin Hai Zhu; Mo Lei Shen
Journal:  Cell J       Date:  2022-04-27       Impact factor: 3.128

10.  linc00968 inhibits the tumorigenesis and metastasis of lung adenocarcinoma via serving as a ceRNA against miR-9-5p and increasing CPEB3.

Authors:  Huaping Tang; Xiaolei Han; Yan Feng; Yueqin Hao
Journal:  Aging (Albany NY)       Date:  2020-11-05       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.